title: Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection.
abstract: During acute and early human immunodeficiency virus type 1 (HIV-1) infection (AEI) more than 50% of CD4+ T cells are preferentially depleted from the gastrointestinal (GI) lamina propria. To better understand the underlying mechanisms, we studied virological and immunological events within the peripheral blood (PB) and GI tract during AEI. A total of 32 AEI subjects and 18 uninfected controls underwent colonic biopsy. HIV-1 viral DNA and RNA levels were quantified in CD4+ T cells derived from the GI tract and PB by using real-time PCR. The phenotype of infected cells was characterized by using combinations of immunohistochemistry and in situ hybridization. Markers of immunological memory, activation, and proliferation were examined by flow cytometry and immunohistochemistry, and the host-derived cytotoxic cellular response was examined by using immunohistochemistry. GI CD4+ T cells harbored, on average, 13-fold higher HIV-1 viral DNA levels and 10-fold higher HIV-1 RNA levels than PB CD4+ T cells during AEI. HIV-1 RNA was detected in both "activated" and "nonactivated" mucosal CD4+ T cells. A significantly higher number of activated and proliferating T cells were detected in the GI tract compared to the PB, and a robust cytotoxic response (HIV-1 specificity not determined) was detected in the GI tract as early as 18 days postinfection. Mucosal CD4+ T-cell depletion is multifactorial. Direct viral infection likely accounts for the earliest loss of CD4+ T cells. Subsequently, ongoing infection of susceptible CD4+ T cells, along with activation-induced cellular death and host cytotoxic cellular response, are responsible for the persistence of the lesion.
authors.affiliation: Aaron Diamond AIDS Research Center, Rockefeller University, 455 First Ave., 7th Fl., New York, NY 10016, USA.
authors.forename: Saurabh
authors.initials: S
authors.lastname: Mehandru
authors.forename: Michael A
authors.initials: MA
authors.lastname: Poles
authors.forename: Klara
authors.initials: K
authors.lastname: Tenner-Racz
authors.forename: Victoria
authors.initials: V
authors.lastname: Manuelli
authors.forename: Patrick
authors.initials: P
authors.lastname: Jean-Pierre
authors.forename: Peter
authors.initials: P
authors.lastname: Lopez
authors.forename: Anita
authors.initials: A
authors.lastname: Shet
authors.forename: Andrea
authors.initials: A
authors.lastname: Low
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mohri
authors.forename: Daniel
authors.initials: D
authors.lastname: Boden
authors.forename: Paul
authors.initials: P
authors.lastname: Racz
authors.forename: Martin
authors.initials: M
authors.lastname: Markowitz
mesh_terms: D000208:Acute Disease; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology / Q000821:virology; D003602:Cytotoxicity, Immunologic; D004279:DNA, Viral / Q000097:blood; D005260:Female; D005434:Flow Cytometry; D041981:Gastrointestinal Tract / Q000276:immunology* / Q000821:virology*; D015658:HIV Infections / Q000276:immunology* / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification / Q000472:pathogenicity*; D006801:Humans; D007150:Immunohistochemistry; D007156:Immunologic Memory; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000821:virology; D008213:Lymphocyte Activation; D008297:Male; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
chemical_list: D004279:DNA, Viral; D012367:RNA, Viral